论文部分内容阅读
目的:对校正改良早期预警评分(MEWS)联合疼痛评分(VAS)对急性胰腺炎患者预后的评估价值进行评价分析,为今后的临床诊治工作提供可靠的参考依据。方法:抽取在2011年9月~2013年9月间我院收治的急性胰腺炎患者86例,对其展开MEWS与VAS评分,并结合评分结果将患者分成濒危组、危重组、急症组、次急症组、非急症组,对比分析各组患者的预后情况。结果:经比较发现不同组别者的死亡率存在明显差异,表现为病情越危急死亡率越高(P<0.05),且存活组患者MEWS与VAS评分均较死亡组发生明显降低(P<0.05)。结论:经校正改良早期预警评分联合疼痛评分对急性胰腺炎进行预后评估的结果相对准确,临床价值显著,值得关注。
OBJECTIVE: To evaluate and evaluate the evaluation value of modified improved early warning score (MEWS) joint pain score (VAS) in the prognosis of patients with acute pancreatitis and provide reliable reference for future clinical diagnosis and treatment. Methods: Totally 86 acute pancreatitis patients admitted to our hospital from September 2011 to September 2013 were selected for MEWS and VAS score. The patients were divided into three groups: endangered group, critically ill group, emergency group, Emergency group, non-emergency group, comparative analysis of the prognosis of patients in each group. Results: The mortality rates of different groups were significantly different. The more severe the disease was, the higher the mortality was (P <0.05), and the scores of MEWS and VAS in survival group were significantly lower than those in death group (P <0.05) ). CONCLUSION: The results of the prognostic assessment of acute pancreatitis by the modified improved early warning score combined with pain score are relatively accurate and of significant clinical value, which deserve attention.